Gary Jacob - May 16, 2022 Form 3 Insider Report for OKYO Pharma Ltd (OKYO)

Role
Chief Executive Officer, Director
Signature
/s/ Gary S. Jacob
Stock symbol
OKYO
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
3
Date filed
5/16/2022, 05:44 PM
Previous filing
Jan 5, 2022
Next filing
May 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OKYO Option (right to buy) May 16, 2022 Ordinary Shares 40M $0.07 Direct F1
holding OKYO Option (right to buy) May 16, 2022 Ordinary Shares 13M $0.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% will vest each year on January 7, beginning on January 6, 2021.
F2 25% will vest each year on January 7, beginning on August 31, 2021.